Literature DB >> 454670

Preparation and properties of polyethylene glycol-trypsin adducts.

A Abuchowski, F F Davis.   

Abstract

The covalent attachment of polyethylene glycol of 5000 daltons to non-essential groups on trypsin produces an adduct that no longer precipitates with anti-trypsin antibody. In comparison with trypsin, polyethylene glycol-trypsin preparations show equal or greater activity against N-alpha-benzoyl-L-arginine ethyl ester, about one-fourth activity against angiotensin II, and little activity against bovine liver catalase. The polyethylene glycol-trypsin adduct dissolves soft blood clots at one-fourth the rate of trypsin. Soybean trypsin inhibitor produces two-thirds inhibition of the adduct under conditions that cause complete inhibition of trypsin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454670     DOI: 10.1016/0005-2795(79)90110-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Emerging synthetic approaches for protein-polymer conjugations.

Authors:  Rebecca M Broyer; Gregory N Grover; Heather D Maynard
Journal:  Chem Commun (Camb)       Date:  2011-01-12       Impact factor: 6.222

Review 2.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 3.  Pharmacokinetics and pharmacodynamics of pegfilgrastim.

Authors:  Bing-Bing Yang; Anna Kido
Journal:  Clin Pharmacokinet       Date:  2011-05       Impact factor: 6.447

4.  N-terminal site-specific mono-PEGylation of epidermal growth factor.

Authors:  Haeshin Lee; Il Ho Jang; Sung Ho Ryu; Tae Gwan Park
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 5.  Polymer conjugates. Pharmacokinetic considerations for design and development.

Authors:  R Duncan; F Spreafico
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

Review 6.  Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery.

Authors:  Matthew Palombo; Manjeet Deshmukh; Daniel Myers; Jieming Gao; Zoltan Szekely; Patrick J Sinko
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-23       Impact factor: 13.820

7.  PEGylation and antioxidant effects of a human glutathione peroxidase 1 mutant.

Authors:  Guang-Yuan Zhang; Yan-Wei Wang; Li-Ying Guo; Liang-Ru Lin; Shao-Peng Niu; Chang-Hao Xiong; Jing-Yan Wei
Journal:  Aging (Albany NY)       Date:  2022-01-12       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.